Marsh Chiropractic, Ps | |
19201 108th Ave Se, #101, Renton, WA 98055-7379 | |
(253) 859-6441 | |
(253) 859-9437 |
Full Name | Marsh Chiropractic, Ps |
---|---|
Type | Facility |
Speciality | Massage Therapist |
Location | 19201 108th Ave Se, Renton, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063570539 | NPI | - | NPPES |
124679 | Other | WA | LABOR AND INDUSTRIES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | (* (Not Available)) | Primary |
225700000X | Massage Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Marsh Chiropractic, Ps 19201 108th Ave Se, #101, Renton, WA 98055-7379 Ph: (253) 859-6441 | Marsh Chiropractic, Ps 19201 108th Ave Se, #101, Renton, WA 98055-7379 Ph: (253) 859-6441 |
News Archive
A new study on prostate cancer describes a novel class of drugs developed by UT Southwestern Medical Center researchers that interrupts critical signaling needed for prostate cancer cells to grow.
Exposure to chemical pollutants is of growing concern to regulators, health workers, and environmentalist groups alike. Now, researchers in the US and Russia have demonstrated that samples of human bone can act as a biological marker for dozens of metals and toxic elements across the periodic table. They describe details in a study published in the International Journal of Environment and Health.
MEDNAX, Inc. today reported earnings per share of 94 cents for the three months ended March 31, 2011, that were driven by strong revenue growth from both acquisitions and same-unit revenue, that led to operating margin expansion.
CEL-SCI Corporation announced today it has received approval from seven hospital Institutional Review Boards in India to begin enrollment of subjects for a Phase III clinical trial of Multikine, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.
Students who struggle to learn mathematics may have a neurocognitive disorder that inhibits the acquisition of basic numerical and arithmetic concepts, according to a new paper by University of Minnesota and British researchers. Called developmental dyscalculia, the disorder affects roughly the same number of people as dyslexia but has received much less attention (and research funding).
› Verified 5 days ago